Trial · NCT05552300
Superselective Adrenal Arterial Embolization for Resistant Hypertension
NCT05552300, Not applicable, Unknown, First Affiliated Hospital of Chengdu Medical College
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Superselective Adrenal Arterial Embolization for Resistant Hypertension. Trials, record NCT05552300. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05552300
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Superselective Adrenal Arterial Embolization for Resistant Hypertension
- NCT number
- NCT05552300
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 144 participants, estimated
- Lead sponsor
- First Affiliated Hospital of Chengdu Medical College
- Conditions
- Resistant Hypertension
- Interventions
- SAAE, traditional triple antihypertensive treatment
- First posted
- 2022-09-23
- Last updated
- 2022-09-23
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change of 24-h average systolic blood pressure | 6-month | Difference in the change of 24-h average systolic blood pressure between the intervention and control group |
| Secondary | Change of 24-h average diastolic blood pressure, daytime mean systolic blood pressure, daytime mean diastolic blood pressure, and nighttime average systolic and diastolic blood pressure | 6-month | Difference in the change of 24-h average diastolic blood pressure, daytime mean systolic blood pressure, daytime mean diastolic blood pressure, and nighttime average systolic and diastolic blood pressure between the intervention and control group |
| Secondary | Change of the number of antihypertensive medications | 6-month | Difference in the change of the number of antihypertensive medications between the intervention and control group |
| Secondary | Change of home systolic and diastolic pressure | 6-month | Difference in the change of home systolic and diastolic pressure between the intervention and control group |
| Secondary | Change of office systolic and diastolic pressure | 6-month | Difference in the change of office systolic and diastolic pressure between the intervention and control group |
| Secondary | Change of blood electrolytes (K+, Na +) | 6-month | Difference in the change of blood electrolytes (K+, Na + in mmol/L) between the intervention and control group |
| Secondary | Change of plasma aldosterone | 6-month | Difference in the change of plasma aldosterone (pg/mL) between the intervention and control group |
| Secondary | Change of plasma cortisol | 6-month | Difference in the change of plasma cortisol (nmol/L) between the intervention and control group |
| Secondary | Change of plasma renin measured | 6-month | Difference in the change of plasma renin (pg/ml) between the intervention and control group |
| Secondary | Change of liver enzymes | 6-month | Difference in the change of liver enzymes (ALT, AST in IU/L) between the intervention and control group |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05552300
GET https://conductscience.org/api/trials/v1/NCT05552300/registered